Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Jul 15, 2022; 14(7): 1337-1347
Published online Jul 15, 2022. doi: 10.4251/wjgo.v14.i7.1337
Table 1 Characteristics of the patients and lesions

Total
Number of patients323
Male sex, n (%)181 (56.0)
Age, mean ± SD, yr64.7 ± 10.5
Number of lesions341
Size, median (IQR), cm2.0 (1.5-3.0)
Location, n (%)
Caecum and ascending colon137 (40.2)
Transverse colon42 (12.3)
Descending colon22 (6.5)
Sigmoid45 (13.2)
Rectum95 (27.9)
LST subtype, n (%)
G-NM152 (44.6)
G-H61 (17.9)
NG-PD62 (18.2)
NG-FE66 (19.4)
HGD/carcinoma, n (%)204 (59.8)
Carcinoma in situ, n (%)173 (50.7)
SMI, n (%)31 (9.1)
Deep SMI, n (%)12 (3.5)
Endoscopically unresectable, n (%)16 (4.7)
Table 2 Characteristics of laterally spreading tumor subtypes

G-NM (n = 152)
G-H (n = 61)
NG-PD (n = 62)
NG-FE (n = 66)
Size, median (IQR), cm2.5 (1.8-4.0)1.8 (1.5-2.4)1.8 (1.5-2.5)1.5 (1.3-1.9)
Location, n (%)
Right-sided colon61 (40.1)42 (68.9)32 (51.6)44 (66.7)
Caecum25 (16.4)16 (26.2)4 (6.4)4 (6.1)
Ascending colon31 (20.4)19 (31.1)12 (19.4)26 (39.4)
Transverse colon5 (3.3)7 (11.5)16 (25.8)14 (21.2)
Descending colon5 (3.3)3 (4.9)5 (8.1)9 (13.6)
Rectosigmoid86 (56.6)16 (26.2)25 (40.3)13 (19.7)
Sigmoid21 (13.8)4 (6.6)11 (17.7)9 (13.6)
Rectum65 (42.8)12 (19.7)14 (22.6)4 (6.1)
HGD/carcinoma rate, n (%)117 (77.0)18 (29.5)53 (85.5)16 (24.2)
Carcinoma in situ, n (%)106 (69.7)18 (29.5)35 (56.4)14 (21.2)
SMI rate, n (%)11 (7.2)0 (0)18 (29.0)2 (3.0)
Deep SMI rate, n (%)4 (2.6)0 (0)8 (12.9)0 (0)
Endoscopically unresectable, n (%)7 (4.6)0 (0)9 (14.5)0 (0)
Table 3 Univariate and multivariate analyses of predictors for high-grade dysplasia /carcinoma
Univariate
Multivariate
OR (95%CI)
P value
OR (95%CI)
P value
LST subtype
NG-FE1-1-
NG-PD18.4 (7.4-45.4)< 0.00116.8 (6.5-43.5)< 0.001
G-NM10.4 (5.3-20.6)< 0.0017.8 (3.8-16.1)< 0.001
G-H1.3 (0.6-2.9)0.5041.1 (0.5-2.4)0.871
Location
Non-rectosigmoid1-
Rectosigmoid2.3 (1.5-3.7)< 0.001
Size, cm
< 21-1-
≥ 22.6 (1.6-4.0)< 0.0012.2 (1.3-3.9)0.005
Non-lifting sign
Negative1-1-
Positive4.0 (1.6-9.8)0.0033.3 (1.2-9.2)0.024
Table 4 Univariate and multivariate analyses of predictors for submucosal invasion and deep submucosal invasion
Univariate
Multivariate
OR (95%CI)
P value
OR (95%CI)
P value
Risk factors for SMI
LST subtype
Non-NG-PD1-1-
NG-PD8.6 (3.9-18.7)< 0.0019.1 (3.9-21.0)< 0.001
Location
Non-rectosigmoid1-1-
Rectosigmoid2.9 (1.3-6.3)0.0073.2 (1.4-7.6)0.007
Non-lifting sign
Negative1-1-
Positive4.8 (2.0-11.3)< 0.0013.0 (1.2-8.0)0.023
Risk factors for deep SMI
LST subtype
Non-NG-PD11
NG-PD11.3 (3.3-39.1)< 0.00113.3 (3.7-47.9)< 0.001
Location
Non-rectosigmoid11
Rectosigmoid7.8 (1.7-36.2)0.0098.7 (1.8-42.3)0.007
Non-lifting sign
Negative1
Positive5.2 (1.5-18.6)0.010
Table 5 Univariate and multivariate analyses of predictors for endoscopically unresectable laterally spreading tumors
Univariate
Multivariate
OR (95%CI)
P value
OR (95%CI)
P value
LST subtype
Non-NG-PD1-1-
NG-PD7.2 (2.6-20.3)< 0.0017.1 (2.3-22.0)0.001
Location
Non-rectosigmoid1-1-
Rectosigmoid11.1 (2.5-49.7)0.00210.5 (2.2-49.0)0.003
Non-lifting sign
Negative1-1-
Positive6.3 (2.1-18.6)0.0013.5 (1.0-12.0)0.045